Koers Lotus Pharmaceutical Co., Ltd. Taipei Exchange
Aandelen
1795
TW0001795003
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
108 TWD | +0,47% | -4,42% | -.--% |
Omzet 2024 * | 18,82 mld. 577 mln. 540 mln. | Omzet 2025 * | 21,2 mld. 650 mln. 609 mln. | Marktkapitalisatie | 85,42 mld. 2,62 mld. 2,45 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 4,84 mld. 149 mln. 139 mln. | Nettowinst (verlies) 2025 * | 6,2 mld. 190 mln. 178 mln. | EV/omzet 2024 * | 4,84 x |
Nettoschuld 2024 * | 5,71 mld. 175 mln. 164 mln. | Nettoschuld 2025 * | 1,56 mld. 47,95 mln. 44,88 mln. | EV/omzet 2025 * | 4,1 x |
K/w-verhouding 2024 * |
17,5
x | K/w-verhouding 2025 * |
14,3
x | Werknemers | - |
Dividendrendement 2024 * |
1,66% | Dividendrendement 2025 * |
2,32% | Vrij verhandelbaar | 48,47% |
Recentste transcriptie over Lotus Pharmaceutical Co., Ltd.
1 dag | +0,47% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 29-09-14 | |
I ling Tian
DFI | Director of Finance/CFO | - | 01-11-16 |
Ying Ming Yue
COO | Chief Operating Officer | - | 01-12-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 60 | 11-08-14 | |
Director/Board Member | 61 | 23-04-15 | |
Árni Harðarson
BRD | Director/Board Member | 57 | 11-08-14 |
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+32,96% | 704 mld. | |
+28,59% | 577 mld. | |
-3,83% | 348 mld. | |
+18,32% | 327 mld. | |
+5,44% | 288 mld. | |
+14,81% | 234 mld. | |
+4,93% | 198 mld. | |
-9,78% | 194 mld. | |
-3,93% | 147 mld. |
- Beurs
- Aandelen
- Koers 1795
- Koers 1795